Positive Data from Phase 1b/2a Study of Pulmonary Infection Treatment
BiomX has announced positive data from a study assessing the safety and tolerability of BX004 in nine cystic patients.
BiomX has announced positive data from a study assessing the safety and tolerability of BX004 in nine cystic patients.
A study published in the Annals of Intensive Care shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube.
Researchers have long suspected that the ability of TB bacteria to remain dormant, sometimes for decades, stems from their ability to behave based upon past experience.
Rates for central line-associated blood stream infections, catheter-associated urinary tract infections and VAP were all lower after one facility transitioned to a closed ICU.
Read MoreResearchers discovered that tweaking factors in a CF lung model, such as pH balance and oxygen, helped eradicate pathogenic bacteria while minimizing risks of antibiotic resistance.
Read MoreInhaled nitric oxide had significant antibacterial activity against Mycobacterium abscessus (M. abscessus), which can infect the airways of patients with cystic fibrosis.
Read MorePatients with uncontrolled asthma had a unique nasal bacteria composition that included elevated levels of Bacteroidetes, compared to nonasthmatics or asthmatics with controlled asthma.
Read MoreA new study has found that telavancin, a current treatment for hospital-acquired pneumonia, could be a potential treatment against MRSA in patients with cystic fibrosis.
Read MoreRespiratory therapists play a crucial role in minimizing intubated patients’ risk of exposure to MDROs and VAP by following proper protocols solutions that help prevent infections.
Read MoreIn a video for MD Magazine, researchers talk in depth about current and developing agents for...
Read MoreNew research from Lund University in Sweden shows for the first time how bacteria in the airways can help each other replenish vital iron, Science Daily reports.
Read MoreBoosting a key immune process called autophagy with interferon gamma (IFN-γ) could help clear a lethal bacterial infection in cystic fibrosis, a new study suggests.
Read MoreIn addition to the constant threat of ventilator-associated pneumonia, ventilated patients also face dangers from other less common hospital-acquired infections, including waterborne pathogens that can occur during humidification.
Read MoreAn antimicrobial peptide produced by human immune cells can promote mutations in P. aeruginosa bacterium, a common cause of death in cystic fibrosis patients.
Read MoreWhen the bacterium Yersinia pestis enters the lungs, it causes pneumonic plague, a disease that is 100 percent fatal if untreated. The way in which Y. pestis evades the immune system and kills people in a matter of days has largely confounded scientists, until now.
Read More